# Comparison of the Effectiveness Metformin for Deceasing Proliferative Marker in Endometrial Cancer Cells

> **NCT03618472** · NA · COMPLETED · sponsor: **Department of Medical Services Ministry of Public Health of Thailand** · enrollment: 50 (actual)

## Conditions studied

- Metformin
- CA Endometrium

## Interventions

- **DRUG:** Metformin Hydrochloride 850 MG
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03618472
- **Lead sponsor:** Department of Medical Services Ministry of Public Health of Thailand
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-01
- **Primary completion:** 2019-11-30
- **Final completion:** 2020-01-30
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2024-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03618472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03618472, "Comparison of the Effectiveness Metformin for Deceasing Proliferative Marker in Endometrial Cancer Cells". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03618472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*